Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) CEO Mark Okey Decker, Jr. bought 102,668 shares of the stock in a transaction dated Tuesday, June 24th. The shares were acquired at an average price of $6.52 per share, for a total transaction of $669,395.36. Following the completion of the purchase, the chief executive officer now directly owns 102,668 shares in the company, valued at approximately $669,395.36. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Global Medical REIT Stock Performance
Shares of NYSE GMRE traded down $0.08 during trading on Wednesday, reaching $6.49. 1,133,455 shares of the stock traded hands, compared to its average volume of 487,790. The company has a debt-to-equity ratio of 1.44, a current ratio of 0.26 and a quick ratio of 0.26. The stock has a market capitalization of $433.99 million, a P/E ratio of 216.41, a price-to-earnings-growth ratio of 1.12 and a beta of 1.14. Global Medical REIT Inc. has a 52-week low of $6.06 and a 52-week high of $10.46. The company has a 50-day moving average of $6.81 and a 200-day moving average of $7.66.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.22. The business had revenue of $34.60 million for the quarter, compared to analysts' expectations of $35.49 million. Global Medical REIT had a return on equity of 1.68% and a net margin of 5.87%. Analysts forecast that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Cuts Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 9th. Stockholders of record on Friday, June 20th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 9.24%. Global Medical REIT's dividend payout ratio (DPR) is currently 2,000.00%.
Analysts Set New Price Targets
GMRE has been the subject of a number of research analyst reports. Robert W. Baird decreased their price objective on shares of Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Wall Street Zen downgraded shares of Global Medical REIT from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Finally, B. Riley assumed coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They set a "neutral" rating and a $9.00 price target for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $10.44.
Get Our Latest Stock Report on GMRE
Institutional Trading of Global Medical REIT
A number of institutional investors have recently modified their holdings of GMRE. Strs Ohio purchased a new position in Global Medical REIT in the 1st quarter valued at approximately $95,000. Intrua Financial LLC boosted its holdings in shares of Global Medical REIT by 8.4% in the first quarter. Intrua Financial LLC now owns 48,600 shares of the company's stock worth $425,000 after acquiring an additional 3,754 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Global Medical REIT by 13.2% in the first quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company's stock valued at $3,400,000 after purchasing an additional 45,243 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Global Medical REIT by 23,920.0% during the 1st quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company's stock valued at $210,000 after purchasing an additional 23,920 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Global Medical REIT by 10.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,395,416 shares of the company's stock valued at $12,210,000 after purchasing an additional 135,318 shares during the period. 57.52% of the stock is currently owned by hedge funds and other institutional investors.
Global Medical REIT Company Profile
(
Get Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.